Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Randomized, Completed 6 Months of Study	STARTED	Apixaban	2,691
Randomized, Completed 6 Months of Study	STARTED	Enoxaparin + Warfarin	2,704
Randomized, Completed 6 Months of Study	COMPLETED	Apixaban	2,314
Randomized, Completed 6 Months of Study	COMPLETED	Enoxaparin + Warfarin	2,291
Randomized, Completed 6 Months of Study	NOT COMPLETED	Apixaban	377
Randomized, Completed 6 Months of Study	NOT COMPLETED	Enoxaparin + Warfarin	413
Completed Study Follow Up	STARTED	Apixaban	2,617
Completed Study Follow Up	STARTED	Enoxaparin + Warfarin	2,639
Completed Study Follow Up	COMPLETED	Apixaban	2,547
Completed Study Follow Up	COMPLETED	Enoxaparin + Warfarin	2,560
Completed Study Follow Up	NOT COMPLETED	Apixaban	70
Completed Study Follow Up	NOT COMPLETED	Enoxaparin + Warfarin	79

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00643201/flow